1. Home
  2. VERU vs SKIL Comparison

VERU vs SKIL Comparison

Compare VERU & SKIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Veru Inc.

VERU

Veru Inc.

HOLD

Current Price

$2.21

Market Cap

41.9M

Sector

Health Care

ML Signal

HOLD

Logo Skillsoft Corp.

SKIL

Skillsoft Corp.

BUY

Current Price

$5.29

Market Cap

40.2M

Sector

Technology

ML Signal

BUY

Company Overview

Basic Information
Metric
VERU
SKIL
Founded
1971
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
41.9M
40.2M
IPO Year
1996
2019

Fundamental Metrics

Financial Performance
Metric
VERU
SKIL
Price
$2.21
$5.29
Analyst Decision
Strong Buy
Analyst Count
3
0
Target Price
★ $25.67
N/A
AVG Volume (30 Days)
★ 212.5K
37.7K
Earning Date
08-10-2026
12-09-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
★ $16,296,958.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.05
$3.43
52 Week High
$7.33
$14.49

Technical Indicators

Market Signals
Indicator
VERU
SKIL
Relative Strength Index (RSI) 39.74 43.57
Support Level $2.11 $4.86
Resistance Level $2.68 $8.20
Average True Range (ATR) 0.14 0.54
MACD -0.01 -0.01
Stochastic Oscillator 19.77 44.13

Price Performance

Historical Comparison
VERU
SKIL

About VERU Veru Inc.

Veru Inc is a late clinical-stage biopharmaceutical focused on developing medicines for the treatment of cardiometabolic and inflammatory diseases. Its drug development program consists of two late-stage new chemical entities, enobosarm and sabizabulin. Enobosarm, an oral selective androgen receptor modulator, is being developed to make weight reduction by GLP-1 RA drugs more tissue selective for loss of fat and preservation of lean mass, and is planned for a Phase 2b PLATEAU clinical study in obesity. Sabizabulin, an oral microtubule disruptor, is being developed for the treatment of inflammation in atherosclerotic cardiovascular disease to lower high-sensitivity CRP in patients with stable coronary artery disease, with a planned Phase 2 study.

About SKIL Skillsoft Corp.

Skillsoft Corp is a leader in corporate digital learning. The company's segments include Talent Development Solutions and Global Knowledge. Talent Development Solutions brings a foundation of products and customers. TDS enterprise-grade solution serves customers and employees world-wide. TDS Learner is a world-renowned consumer-scale and experiential learning platform that serves learners internationally. The Global Knowledge segment is centered around instructor-led training, or live learning, with face-to-face delivery by experienced trainers, both in-person and virtually.

Share on Social Networks: